$MDXG has made 5 52wk highs in the last six days, closing yesterday at $12.41
This $31 price target was BEFORE the Pfizer/Lilly failure and BEFORE the "multiple buyout offers" language.
DECEMBER 16, 2020 MIMEDX GROUP INC. | MDXG – UPDATE We are raising our price target on MiMedx Group to $31 per share based on extensive new research showing that MiMedx’s Amniofix treatment will be a blockbuster for knee OA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.